Vimta Labs Ltd
NSE: VIMTALABS BSE: 524394
₹380.70
(-5.15%)
Wed, 01 Apr 2026, 08:16 pm
Market Cap17.92B
PE Ratio22.89
Dividend0.25
Commercial Services
Miscellaneous Commercial Services
24.5KVimta Labs Analysis
dividend
- Dividends per share have increased over the past 10 years.
- Dividends paid are covered by earnings (1.6x coverage).
- Vimta Labs's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
- Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
- Vimta Labs's dividend is below the markets top 25% of dividend payers in India (3.08%).
health
- Vimta Labs is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Vimta Labs is profitable, therefore cash runway is not a concern.
- Vimta Labs is profitable, therefore cash runway is not a concern.
- Debt is well covered by operating cash flow (105.5%, greater than 20% of total debt).
- Debt is covered by short term assets, assets are 4.2x debt.
- Vimta Labs's cash and other short term assets cover its long term commitments.
- Interest payments on debt are well covered by earnings (EBIT is 3.2x coverage).
- Vimta Labs's level of debt (13.4%) compared to net worth is satisfactory (less than 40%).
- The level of debt compared to net worth has increased over the past 5 years (2.9% vs 13.4% today).
- High level of physical assets or inventory.
management
- The average tenure for the Vimta Labs board of directors is less than 3 years, this suggests a new board.
- Harita's remuneration is higher than average for companies of similar size in India.
- Harita's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
- The average tenure for the Vimta Labs management team is less than 2 years, this suggests a new team.
misc
- Vimta Labs is not covered by any analysts.
- Vimta Labs has significant price volatility in the past 3 months.
past
- Vimta Labs has delivered over 20% year on year earnings growth in the past 5 years.
- Vimta Labs's 1-year earnings growth is negative, it can't be compared to the 5-year average.
- Vimta Labs used its assets less efficiently than the IN Life Sciences industry average last year based on Return on Assets.
- Vimta Labs's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
- Vimta Labs has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
- Vimta Labs's 1-year earnings growth is negative, it can't be compared to the IN Life Sciences industry average.
value
- Vimta Labs is good value based on assets compared to the IN Life Sciences industry average.
- Vimta Labs is good value based on earnings compared to the IN Life Sciences industry average.
- BSE:524394 is up 18.7% outperforming the Life Sciences industry which returned 2.6% over the past month.
- BSE:524394 is up 18.7% outperforming the market in India which returned 8% over the past month.
- Vimta Labs's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).
- Vimta Labs's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).
- Vimta Labs is overvalued based on earnings compared to the India market.
- 524394 underperformed the Life Sciences industry which returned 36.1% over the past year.
- 524394 underperformed the Market in India which returned -14.5% over the past year.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800